2020 Outlook: MA ‘Winners’ Must Focus on Differentiation, Integration

With early signs of strong enrollment growth in 2020 and a healthy pay outlook in 2021 given the elimination of the Affordable Care Act health insurer fee and an anticipated rate increase, the sun continues to shine on Medicare Advantage. Even as momentum around Medicare for All and other universal health care proposals continues to build, industry experts say MA remains the safest game in town and will likely serve as a road map for any such health care reform. At the same time, insurers will continue to face program hurdles such as evolving audit practices, and they may want to consider strategic investments to boost their integrated care capabilities and remain competitive.

In our annual roundup of forward-looking remarks, industry experts share their predictions on the challenges, policy developments and trends that are likely to impact the MA market in 2020 and beyond.

© 2023 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

woman-getting-in-ride-share
February 2

Medicaid Beneficiaries Are Unequally Served by Non-Emergency Medical Transportation

READ MORE
magnifying-glass
February 2

With Final RADV Rule Out, MAOs Are Advised to Clean Up Risk Adjustment Practices

READ MORE
application-for-health-insurance
February 2

As Medicaid Redeterminations Loom, MCOs Can Help States Ease the Process

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today